Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gordon Penn

Optometrist, Corneal and Contact Management Viera, FL Doctor of Optometry

NPI 1417960881 CMS profile 830538

8500 N Wickham Rd, Viera, FL 32940

Open in the dashboard

General payments

$7,397

80 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gordon Penn of Viera, FL is reported in the CMS Open Payments database as having received $7,397 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $337 7
2024 General $1,111 13
2023 General $2,411 20
2022 General $415 10
2021 General $1,593 14
2020 General $92 2
2019 General $1,438 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gordon Penn
  • Optometrist, Corneal and Contact Management median
  • Middle half of Optometrist, Corneal and Contact Management
  • National median

In program year 2025, general payments to Gordon Penn were reported at $337. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.

Show as a table
Year Gordon Penn Optometrist, Corneal and Contact Management median Middle half National median
2019 $1,438 $203 $84–$530 $163
2020 $92 $88 $35–$234 $114
2021 $1,593 $143 $54–$353 $132
2022 $415 $167 $65–$422 $149
2023 $2,411 $195 $76–$549 $160
2024 $1,111 $202 $85–$523 $164
2025 $337 $227 $95–$604 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $4,922 36 payments
  2. Johnson & Johnson Vision Care, Inc. $886 11 payments
  3. CooperVision Inc. $574 17 payments
  4. AbbVie, Inc. $528 6 payments
  5. Bausch & Lomb Americas Inc. $370 7 payments
  6. Allergan Inc. $105 2 payments
  7. Bausch & Lomb, a division of Bausch Health US, LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,039 66 payments
  2. Travel and Lodging $3,351 13 payments
  3. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. AIR OPTIX $3,251 12 payments
  2. DAILIES $1,406 9 payments
  3. Dailies Aqua Comfort Plus $1,115 2 payments
  4. Acuvue $886 11 payments
  5. Precision 1 $374 4 payments
  6. DAILIES TOTAL1 Multifocal $271 1 payment
  7. TOTAL30 $233 10 payments
  8. Multiple Brands Contact Lens $196 7 payments
  9. INFUSE $148 2 payments
  10. Clariti Contact Lens $147 3 payments
  11. Other $638 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Optometry: 120

Drug cost

$47

Median for Optometry: $8,864

Branded share of claims

0%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Latanoprost Generic 15 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist, Corneal and Contact Management in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record